文献速递肺外科

VATS与开胸肺癌纵隔淋巴结清扫质量对比:JCOG1413补充分析

Quality comparison of mediastinal lymph node dissection between video-assisted thoracic surgery and open thoracotomy: a supplementary analysis of the phase 3 Japan Clinical Oncology Group 1413 trial†.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

基于JCOG1413随机对照试验数据,纳入1685例临床I-II期非小细胞肺癌患者(VATS 1251例,开胸434例),采用倾向性评分匹配比较两种入路纵隔淋巴结清扫质量。匹配后每组426例,VATS与开胸的N2升级比例(7.8% vs 7.3%,P=0.795)及淋巴结清扫数目均无显著差异,提示两种入路纵隔淋巴结清扫质量相当。

要点

  • VATS与开胸的N2升级比例无显著差异(7.8% vs 7.3%,P=0.795)。
  • 系统性清扫中位N2淋巴结数两组均为13枚(P=0.236)。

核心结论

  • 临床I-II期NSCLC患者中,VATS与开胸的纵隔淋巴结清扫质量相当,N2升级比例无显著差异。

研究设计与样本

  • JCOG1413 III期随机对照试验的补充分析,探索性纳入1685例患者(VATS 1251例,开胸434例),采用倾向性评分匹配平衡基线特征。

主要发现

  • 1685例中病理N1为141例(8.3%),病理N2为118例(7.0%)。
  • 匹配后每组426例,N2升级比例VATS 7.8% vs 开胸7.3%(P=0.795)。
  • 系统性清扫中位N2淋巴结数两组均为13枚(P=0.236),肺叶特异性清扫两组均为7枚(P=0.720)。
  • 肺叶切除类型对N2升级的影响在两组间无显著差异。

关键数值与推荐

  • N2升级定义为临床N0-N1升级为病理N2的比例。
  • 系统性清扫中位N2淋巴结数两组均为13枚(P=0.236)。
  • 肺叶特异性清扫中位N2淋巴结数两组均为7枚(P=0.720)。

临床怎么用

  • 临床I-II期NSCLC行肺叶切除时,VATS可提供与开胸相当的纵隔淋巴结清扫质量。
  • 杂交与完全VATS入路的淋巴结清扫质量无显著差异,术式选择可依据技术条件。

局限性

  • 本研究为JCOG1413的探索性补充分析,非预设主要终点。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to compare the quality of mediastinal lymph node dissection (LND) during lobectomy for clinical stage I-II non-small cell lung cancer (NSCLC) between video-assisted thoracic surgery (VATS) and open thoracotomy, using data from the Japan Clinical Oncology Group (JCOG) 1413 phase 3, randomized, controlled trial. METHODS: This analysis draws information from JCOG1413, comparing the efficacy of lobe-specific versus systematic LND with standardized LND protocols. A total of 1685 patients were included in this exploratory analysis (1251 VATSs and 434 open thoracotomies). Propensity score matching (PSM) ensured a balanced distribution of patient characteristics. The study's end-point was N2 upstaging, defined as the proportion of upstaging from clinical N0-N1 to pathological N2. RESULTS: Among 1685 patients, 141 (8.3%) and 118 (7.0%) had pathological N1 and N2, respectively. The PSM yielded 852 patients (426 per group). The N2 upstaging proportions (7.8% [VATS] vs 7.3% [open], P = 0.795) and the influence of the lobectomy type on N2 upstaging were not significantly different between the 2 groups. The median number of N2 lymph nodes dissected per defined LND extent was similar (systematic: 13 in both groups, P = 0.236; lobe-specific: 7 in both groups, P = 0.720). Additionally, no significant difference in N2 upstaging was observed between hybrid and complete VATS groups (6.7% in both groups, P =. 982). CONCLUSIONS: This study found no significant differences in N2 upstaging proportions between the VATS and open thoracotomy groups of patients with clinical stage I-II NSCLC. This suggests comparable quality of mediastinal LND in both surgical approaches. CLINICAL TRIAL REGISTRATION: This study is a sub-analysis of the JCOG1413 randomized controlled trial. The JCOG1413 trial is registered with the UMIN Clinical Trials Registry (UMIN0000025530).

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Tsubokawa N, Tsutani Y, Hishida T, et al. Quality comparison of mediastinal lymph node dissection between video-assisted thoracic surgery and open thoracotomy: a supplementary analysis of the phase 3 Japan Clinical Oncology Group 1413 trial†. Eur J Cardiothorac Surg. 2025. PMID: 40578313. doi:10.1093/ejcts/ezaf206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。